Approval of the Comsolidated and Stanalone unaudited financial results for the half year ended 30th September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.4 pts less than Nifty Microcap 250 and 0.2 pts more than its Food Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Shivam Chemicals reported consolidated revenue from operations of ₹13,166.78 lakhs for H1FY26 (ended Sep 30, 2025), up about 39% from ₹9,441.57 lakhs in the same period last year. Total revenue stood at ₹13,257.70 lakhs versus ₹9,517.84 lakhs earlier. Profit before tax rose to ₹252.55 lakhs from ₹87.78 lakhs (nearly 2.9x), and profit after tax jumped to ₹196.51 lakhs from ₹58.02 lakhs (around 3.4x), translating to EPS of ₹1.16 versus ₹0.34. Standalone numbers also showed strong growth, with revenue up about 46% to ₹12,486.95 lakhs and PAT rising to ₹154.60 lakhs from ₹87.82 lakhs. The statutory auditor PSRD & Co. issued an unmodified review report on both sets of results.
Strong top-line and bottom-line growth on a year-on-year basis is a positive signal for shareholders, reflecting improved demand and operating leverage. The PAT growth of over 200% far exceeds the revenue growth, indicating meaningful margin expansion. However, short-term borrowings have nearly doubled, and standalone operating cash flow remains negative, which are points worth watching.